A recent study reveals that patients who discontinue blockbuster slimming jabs like Mounjaro or Wegovy may regain reduced body mass far faster than those who halt conventional lifestyle programs.
Findings released in a leading health publication demonstrates that while overweight individuals often shed substantial amounts of their total mass while undergoing treatment, the weight is regained at an average rate of nearly a kilo each month upon discontinuation.
"Users using such treatments need to be informed of the risk of quick rebound weight gain when the treatment concludes," stated researcher Dr. Susan Jebb.
Such speed of regain suggests a return to starting weight within about 18 months.
Weighing Approaches
The analysis, which looked at dozens of studies involving over 9,000 of participants, contrasted the results of the injectable medications with other pills.
The team emphasize that individuals who lose weight through dieting generally experience a less rapid weight regain—around 100 grams monthly—after stopping.
Understanding the Rapid Rebound
Doctors believe the way of the jabs is key to understanding the amplified rebound.
These medications copy a body's own chemical called GLP-1, which moderates appetite.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production may cause the system to generate a reduced amount of its endogenous GLP-1, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.
"Stopping of this hormone supplement means hunger is unsuppressed, making binge eating far more likely."
A Lifelong Disease?
The NHS suggest the injections for individuals with obesity-related health risks, alongside recommended lifestyle changes.
Many experts contend that, given the likelihood of weight regain, the treatment might need to be long-term.
This opinion is reinforced by pharmaceutical companies, who note that the results "emphasize the long-term character of excess weight," comparing it to managing diseases like high blood pressure.
Patient Accounts
People who have come off the jabs report a sudden return of cravings.
"It felt as if something that goes on and you become starving," described one woman.
The struggle is worsened if users have not established sustainable dietary or behavioural changes during therapy.
Significant Interest
Survey data show that millions of adults in the UK have tried these injections in the last 12 months, with demand being substantial.
- Use is more common among women compared to males.
- The middle-aged demographic shows the greatest level of interest.
- Many access the medications through private healthcare rather than public health services.
In conclusion, clinicians caution that while these medications are effective tools for shedding pounds, they are not a permanent solution and lasting health benefits relies on ongoing lifestyle support.
